Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Tirzepatide is classified as a long-acting, lipidated dual incretin receptor agonist peptide, specifically a GLP-1R/GIPR co-agonist.
Last reviewed: 16 July 2026
Shop Now Research updates from Evo Peptides New compounds, COA releases, and exclusive deals for researchers
Why SkinnyRx Reviews Often Vary Experiences differ because pricing visibility, clinician review outcomes, and pharmacy fulfillment occur at separate stages controlled by different parties
CHARLEBOIS: GLP-1 drugs becoming Canadas $3.4 billion food disruption The food industry has always worried about inflation it should now worry about appetite Published May 02, 2026 Last updated May 02, 2026 3 minute read You can save this article by registering for free here
Smits, MM, Galsgaard, KD, Jepsen, SL, Albrechtsen, NW, Hartmann, B, Holst, JJ
US$ 26.52
US$ 28.05
US$ 26.04
US$ 23.85
US$ 24.86
US$ 28.74
